Company / R&D Expense
Heartflow, Inc. R&D Expense History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$64.9M
FY2025
5-year range
$64.9M / $64.9M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#74 of 110
Health Care
What the data says
At $65M, Heartflow, Inc.'s r&d expense ranks #74 of 110 in the Health Care sector.
Based on SEC 10-K filings.
$65M in FY2025.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#74 of 110 in Health CareTop 67% of 110This company $64.9M Sector average $298.2M
▼
-78.2% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $64.9M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026